Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHims & Hers Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | $0.01 | $0.01 | $0.01 |
| Q2 2024 | 2 | $0.04 | $0.05 | $0.04 |
| Q3 2024 | 2 | $0.10 | $0.12 | $0.11 |
| Q4 2024 | 6 | $0.13 | $0.24 | $0.18 |
| Q1 2025 | 3 | $0.09 | $0.28 | $0.16 |
| Q2 2025 | 2 | $0.17 | $0.20 | $0.19 |
| Q3 2025 | 2 | $0.19 | $0.22 | $0.21 |
| Q4 2025 | 2 | $0.21 | $0.24 | $0.23 |
| Q1 2026 | 1 | $0.16 | $0.19 | $0.18 |
| Q2 2026 | 1 | $0.16 | $0.19 | $0.18 |
| Q3 2026 | 1 | $0.17 | $0.19 | $0.18 |
| Q4 2026 | 1 | $0.15 | $0.18 | $0.17 |
Hims & Hers Health, Inc. Earnings Date And Information
Hims & Hers Health, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0. The company had revenue of 401.56 M for the quarter and had revenue of 872.00 M for the year. Hims & Hers Health, Inc. has generated $0 earnings per share over the last year ($-0.11 diluted earnings per share) and currently has a price-to-earnings ratio of 56.05. Hims & Hers Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based on prior year's report dates.
Hims & Hers Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | $0.06 | $0.35 | 0.29 | $382.20 M | $401.56 M |
| 08/05/2024 | Q2 2024 | $0.04 | $0.06 | 0.02 | $304.66 M | $315.65 M |
| 05/06/2024 | Q1 2024 | $0.01 | $0.05 | 0.04 | $278.17 M | |
| 02/26/2024 | Q4 2023 | $0.00 | $0.01 | 0 | $246.62 M | |
| 11/06/2023 | Q3 2023 | -$0.03 | -$0.04 | -0 | $220.08 M | $226.70 M |
| 08/07/2023 | Q2 2023 | -$0.06 | -$0.03 | 0.03 | $204.95 M | $207.91 M |
| 05/08/2023 | Q1 2023 | -$0.06 | -$0.05 | 0.01 | $190.77 M | |
| 02/27/2023 | Q4 2022 | -$0.07 | -$0.05 | 0.02 | $167.20 M | |
| 11/07/2022 | Q3 2022 | -$0.11 | -$0.09 | 0.02 | $130.32 M | $144.84 M |
| 08/08/2022 | Q2 2022 | -$0.10 | -$0.10 | 0 | $103.89 M | $113.56 M |
| 05/09/2022 | Q1 2022 | -$0.09 | -$0.08 | 0.01 | $101.31 M | |
| 02/24/2022 | Q4 2021 | -$0.15 | $84.70 M | |||
| 11/10/2021 | Q3 2021 | -$0.14 | -$0.08 | 0.06 | $70.53 M | $74.17 M |
| 08/11/2021 | Q2 2021 | -$0.16 | -$0.05 | 0.11 | $56.49 M | $60.69 M |
| 05/17/2021 | Q1 2021 | -$0.15 | -$0.34 | -0.19 | $52.31 M | |
| 03/22/2021 | Q4 2020 | -$0.07 | $41.47 M | |||
| 11/12/2020 | Q3 2020 | -$0.16 | $41.32 M | |||
| 08/13/2020 | Q2 2020 | -$0.03 | $35.90 M | |||
| 05/13/2020 | Q1 2020 | -$0.17 | $30.06 M | |||
| 03/27/2020 | Q4 2019 | -$0.36 | $24.77 M |
Hims & Hers Health, Inc. Earnings: FAQ's
When is Hims & Hers Health, Inc.'s earnings date?
Hims & Hers Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates.
How can I listen to Hims & Hers Health, Inc.'s earnings conference
call?
The conference call for Hims & Hers Health, Inc.'s latest earnings report can be listened to online.
How can I read Hims & Hers Health, Inc.'s conference call transcript?
The conference call transcript for Hims & Hers Health, Inc.'s latest earnings report can be read online.
How much revenue does Hims & Hers Health, Inc. generate each year?
Hims & Hers Health, Inc. (:HIMS) has a recorded annual revenue of $872.00 M.
How much profit does Hims & Hers Health, Inc. generate each year?
Hims & Hers Health, Inc. (:HIMS) has a recorded net income of $872.00 M. Hims & Hers Health, Inc. has generated $-0.11 earnings per share over the last four quarters.
What is Hims & Hers Health, Inc.'s price-to-earnings ratio?
Hims & Hers Health, Inc. (:HIMS) has a price-to-earnings ratio of 56.05 and price/earnings-to-growth ratio is 0.12.